+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vendor Neutral Archive & PACS Market Size, Share & Trends Analysis Report By Product Type, By Vendor Type, By Deployment, By End User, By Application, By Modality, By Regional Outlook and Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 496 Pages
  • September 2024
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 6010326
The Global Vendor Neutral Archive (VNA) & PACS Market size is expected to reach USD8.3 billion by 2031, rising at a market growth of 9.3% CAGR during the forecast period.

In 2023, the Europe region generated 29% revenue share in the market. The European Union is working towards creating the European Health Data Space to improve data sharing and interoperability across member states. VNA systems are crucial for achieving the interoperability required for such initiatives by providing a standardized platform for managing diverse imaging data. European healthcare systems are pushing for medical imaging and data management standardization. PACS and VNA systems support this goal by enabling the integration of imaging data from various sources into a single, standardized platform.



The major strategies followed by the market participants are Partnerships as the key developmental strategy to keep pace with the changing demands of end users. For instance, In February, 2024, Hyland Software, Inc. announced the partnership with iTernity, a software company that enhances healthcare data storage. Their partnership integrates eternity iCAS FS with Hyland Healthcare's Acuo VNA, an advanced platform consolidating imaging data from various sources into a unified repository, supporting DICOM and multimedia formats for seamless integration. Moreover, In October, 2022, GE HealthCare Technologies, Inc.

teamed up with Tribune Health, a Software company to enhance digital pathology with integrated solutions. The collaboration aims to merge Tribun’s Health Suite data with GE’s VNA, Edison Catalog, for a comprehensive patient record. This integration will improve pathology report accuracy, speed up diagnoses, and foster collaboration in oncology.

KBV Cardinal Matrix - Market Competition Analysis


Based on the Analysis presented in the KBV Cardinal matrix; IBM Corporation is the forerunner in the Vendor Neutral Archive (VNA) & PACS Market. Companies such as Siemens AG, Fujifilm Holdings Corporation, and Canon, Inc. are some of the key innovators in Vendor Neutral Archive (VNA) & PACS Market. In November, 2020, Siemens Healthineers came into a partnership with the University of Iowa Health Care (UI Healthcare), a comprehensive academic medical center providing world-class healthcare & health-related outreach services to all Iowans. The partnership aimed to provide Iowans with access to cutting-edge medical imaging technology as well as leverage AI and data analytics to enhance the performance & efficiency of medical imaging which would expand research opportunities and invest in training & development for staff & students.



COVID-19 Impact Analysis

During the COVID-19 pandemic, the global supply chains for VNA and PACS systems experienced significant disruptions. Lockdowns, travel restrictions, and logistical challenges led to delays in delivering critical hardware components and system parts, affecting the ability to deploy and maintain these systems. Many VNA and PACS, hardware manufacturing facilities, faced temporary closures or reduced operations due to COVID-19. This resulted in delays in production schedules and supply shortages, impacting the availability of necessary components for system implementation. Thus, the COVID-19 pandemic had a negative impact on the market.

Market Growth Factors

Healthcare organizations increasingly seek unified platforms that allow for centralized medical data management. VNA solutions can store and manage imaging data from various modalities and departments in a single, accessible repository. This integration supports seamless data access and management across different healthcare settings, critical for comprehensive patient care. In conclusion, the rising demand for integrated healthcare systems and solutions drives the market's growth.

Additionally, Healthcare providers are using a variety of imaging modalities (e.g., MRI, CT scans, X-rays), each producing data in different formats. VNAs offer a standardized platform for storing and managing data from these diverse modalities, enabling seamless integration and access across different systems. This integration is crucial for ensuring that imaging data can be easily accessed and interpreted regardless of the source. Therefore, the growing need for interoperability and data sharing propels the market's growth.

Market Restraining Factors

VNA and PACS systems deployment requires substantial capital expenditure for hardware, software, and infrastructure. High-performance servers, storage systems, and network infrastructure are needed to support the complex requirements of these systems. The costs associated with acquiring and maintaining this infrastructure can be prohibitive, especially for smaller healthcare facilities and organizations. In conclusion, VNA and PACS solutions' high initial costs and implementation challenges are hindering the market's growth.



The leading players in the market are competing with diverse innovative offerings to remain competitive in the market. The above illustration shows the percentage of revenue shared by some of the leading companies in the market. The leading players of the market are adopting various strategies in order to cater demand coming from the different industries. The key developmental strategies in the market are Partnerships & Collaborations.

Driving and Restraining Factors

Drivers

  • Rising Demand For Integrated Healthcare Systems And Solutions
  • Growing Need For Interoperability And Data Sharing
  • Rising Incidence Of Chronic Diseases And The Aging Population

Restraints

  • High Initial Costs And Implementation Challenges Of Vna And Pacs Solutions
  • Data Security And Privacy Concerns In Digital Image Storage And Sharing

Opportunities

  • Rising Adoption Of Cloud-Based Solutions For Medical Data Management
  • Increasing Automation Of Workflow Processes Through Ai And Ml

Challenges

  • Rapid Technological Advancements And System Obsolescence
  • Infrastructure Limitations In Rural And Underserved Areas

Product Type Outlook

Based on product type, the market is divided into VNA and PACS. In 2023, the PACS segment attained 43% revenue share in the market. Picture Archiving and Communication Systems (PACS) provide a centralized repository for medical imaging data. This centralization ensures that imaging data from various modalities and sources are stored in one location, making it easier for healthcare professionals to access and manage patient images.

Vendor Type Outlook

By vendor type, the market is divided into independent vendors and third-party vendors. The third-party vendor segment procured 40% revenue share in the market in 2023. Third-party vendors provide VNA and PACS solutions agnostic to specific imaging equipment or software providers. This neutrality allows for seamless integration with various existing systems from different manufacturers, enabling healthcare organizations to consolidate and manage their imaging data more effectively.



Deployment Outlook

Based on deployment mode, the market is categorized into on-premise, cloud-based, and hybrid model. In 2023, the cloud-based segment registered 32% revenue share in the market. Cloud-based solutions offer exceptional scalability, allowing healthcare organizations to expand their storage capacities in response to the increasing volumes of imaging data. This scalability ensures that cloud-based VNA and PACS systems can efficiently accommodate growing data needs without requiring significant upfront investment in physical infrastructure.

End User Outlook

On the basis of end user, the market is divided into hospitals & clinics, diagnostic centers, and others. The diagnostic centers segment held 21% revenue share in the market in 2023. Diagnostic centers increasingly rely on advanced imaging technologies and data management systems to enhance their services and improve patient care. The integration of VNA and PACS solutions enables these facilities to streamline their operations, facilitate collaboration with hospitals, and provide timely diagnostic insights.

Application Outlook

Based on application, the market is divided into cardiology, orthopedic, oncology, neurology, obstetrics & gynecology, and others. The oncology segment attained 22% revenue share in the market in 2023. Oncology involves using various imaging modalities, such as PET, CT, MRI, and ultrasound, to diagnose, stage, and monitor cancer. VNA and PACS systems are crucial for integrating these diverse imaging formats into a unified system, enabling comprehensive management and review of patient data across multiple modalities.

Modality Outlook

On the basis of modality, the market is segmented into computed tomography, mammography, MRI, ultrasound, X-rays, and PET. In 2023, the X-rays segment attained 22% revenue share in the market. X-ray imaging remains one of healthcare's most frequently used diagnostic tools due to its effectiveness in detecting various conditions, from fractures to infections. Daily, the high volume of X-ray images generated drives significant demand for storage and management solutions, such as VNA and PACS. X-rays are utilized in routine and emergency settings, making them a staple in medical imaging.

Market Competition and Attributes



The Vendor Neutral Archive (VNA) & PACS Market exhibits intense competition among various brands and manufacturers. Emerging players focus on innovative features, superior sound quality, and affordability to capture market share. Companies are investing in advanced technologies like Dolby Atmos and wireless connectivity, enhancing user experience while competing on price and product differentiation.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 39% revenue share in the market in 2023. North America, particularly the United States and Canada, boasts a highly advanced and sophisticated healthcare infrastructure. This development creates a robust environment for adopting advanced imaging solutions like VNA and PACS, integral to modern healthcare delivery. The healthcare sector in North America is quick to adopt new technologies.

Recent Strategies Deployed in the Market

  • Feb-2024: Fujifilm Holdings Corporation unveiled Synapse VNA and Synapse Radiology PACS have been ranked #1 in the 2024 Best in KLAS Awards: Software and Services. This recognition highlights their excellence in diagnostic and enterprise imaging, helping healthcare organizations manage imaging data and enhance patient care across the healthcare ecosystem.
  • Nov-2023: Hyland Software, Inc. unveiled its advanced diagnostic imaging and point-of-care solutions at this year’s RSNA conference. The company aims to address healthcare challenges like staff shortages and increasing demand by offering technologies that enhance patient information and decision-making.
  • Feb-2023: Fujifilm Holdings Corporation announced the acquisition of Inspirata’s global digital pathology business, including the Dynamyx system. This acquisition strengthens Fujifilm’s healthcare capabilities, enhancing collaboration between pathology, radiology, and oncology, and improving integrated care delivery across the enterprise. Inspirata is a Tampa-based company specializing in cancer informatics.
  • Sep-2022: IBM Corporation unveiled data, analytics, and technology solutions for the health industry. Their Enterprise Imaging solutions include IBM iConnect Access, a zero-download image viewer, IBM iConnect Enterprise Archive, a VNA, and Merge PACS, an AI-ready workflow platform.
  • Apr-2022: Koninklijke Philips N.V. teamed up with Prisma Health, an 814-bed tertiary referral hospital and academic center to enhance enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions. This collaboration aims to improve patient care, and clinical performance, and achieve the quadruple aim: better satisfaction, lower costs, and enhanced outcomes for South Carolinians.

List of Key Companies Profiled

  • Hyland Software, Inc.
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • Fujifilm Holdings Corporation
  • IBM Corporation
  • Carestream Health, Inc. (Onex Corporation)
  • Novarad Enterprise Healthcare Solutions
  • Canon, Inc. (Canon Medical Systems Corporation)
  • INFINITT Healthcare Co. Ltd.

Market Report Segmentation

By Product Type

  • VNA
  • Multi-Department VNA
  • Department VNA
  • Multi-Site VNA
  • PACS
  • Multi-Department PACS
  • Department PACS
  • Multi-Site PACS

By Vendor Type

  • Independent Vendor
  • Third-party Vendor

By Deployment

  • On-Premise
  • Cloud-Based
  • Hybrid Model

By End User

  • Hospitals & Clinics
  • Diagnostic Centers
  • Others

By Application

  • Cardiology
  • Orthopedic
  • Oncology
  • Neurology
  • Obstetrics & Gynecology
  • Others

By Modality

  • Computed Tomography
  • Mammography
  • MRI
  • Ultrasound
  • X-Rays
  • PET

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Vendor Neutral Archive (VNA) & PACS Market, by Product Type
1.4.2 Global Vendor Neutral Archive (VNA) & PACS Market, by Vendor Type
1.4.3 Global Vendor Neutral Archive (VNA) & PACS Market, by Deployment
1.4.4 Global Vendor Neutral Archive (VNA) & PACS Market, by End User
1.4.5 Global Vendor Neutral Archive (VNA) & PACS Market, by Application
1.4.6 Global Vendor Neutral Archive (VNA) & PACS Market, by Modality
1.4.7 Global Vendor Neutral Archive (VNA) & PACS Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2020, Aug - 2024, Feb) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Global Vendor Neutral Archive (VNA) & PACS Market by Product Type
5.1 Global VNA Market by Region
5.2 Global Vendor Neutral Archive (VNA) & PACS Market by VNA Type
5.2.1 Global Multi-Department VNA Market by Region
5.2.2 Global Department VNA Market by Region
5.2.3 Global Multi-Site VNA Market by Region
5.3 Global PACS Market by Region
5.4 Global Vendor Neutral Archive (VNA) & PACS Market by PACS Type
5.4.1 Global Multi-Department PACS Market by Region
5.4.2 Global Department PACS Market by Region
5.4.3 Global Multi-Site PACS Market by Region
Chapter 6. Global Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
6.1 Global Independent Vendor Market by Region
6.2 Global Third-party Vendor Market by Region
Chapter 7. Global Vendor Neutral Archive (VNA) & PACS Market by Deployment
7.1 Global On-Premise Market by Region
7.2 Global Cloud-Based Market by Region
7.3 Global Hybrid Model Market by Region
Chapter 8. Global Vendor Neutral Archive (VNA) & PACS Market by End User
8.1 Global Hospitals & Clinics Market by Region
8.2 Global Diagnostic Centers Market by Region
8.3 Global Others Market by Region
Chapter 9. Global Vendor Neutral Archive (VNA) & PACS Market by Application
9.1 Global Cardiology Market by Region
9.2 Global Orthopedic Market by Region
9.3 Global Oncology Market by Region
9.4 Global Neurology Market by Region
9.5 Global Obstetrics & Gynecology Market by Region
9.6 Global Others Market by Region
Chapter 10. Global Vendor Neutral Archive (VNA) & PACS Market by Modality
10.1 Global Computed Tomography Market by Region
10.2 Global Mammography Market by Region
10.3 Global MRI Market by Region
10.4 Global Ultrasound Market by Region
10.5 Global X-Rays Market by Region
10.6 Global PET Market by Region
Chapter 11. Global Vendor Neutral Archive (VNA) & PACS Market by Region
11.1 North America Vendor Neutral Archive (VNA) & PACS Market
11.1.1 North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.1.1 North America VNA Market by Region
11.1.1.2 North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.1.2.1 North America Multi-Department VNA Market by Country
11.1.1.2.2 North America Department VNA Market by Country
11.1.1.2.3 North America Multi-Site VNA Market by Country
11.1.1.3 North America PACS Market by Region
11.1.1.4 North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.1.4.1 North America Multi-Department PACS Market by Country
11.1.1.4.2 North America Department PACS Market by Country
11.1.1.4.3 North America Multi-Site PACS Market by Country
11.1.2 North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.2.1 North America Independent Vendor Market by Region
11.1.2.2 North America Third-party Vendor Market by Region
11.1.3 North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.3.1 North America On-Premise Market by Country
11.1.3.2 North America Cloud-Based Market by Country
11.1.3.3 North America Hybrid Model Market by Country
11.1.4 North America Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.4.1 North America Hospitals & Clinics Market by Country
11.1.4.2 North America Diagnostic Centers Market by Country
11.1.4.3 North America Others Market by Country
11.1.5 North America Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.5.1 North America Cardiology Market by Country
11.1.5.2 North America Orthopedic Market by Country
11.1.5.3 North America Oncology Market by Country
11.1.5.4 North America Neurology Market by Country
11.1.5.5 North America Obstetrics & Gynecology Market by Country
11.1.5.6 North America Others Market by Country
11.1.6 North America Vendor Neutral Archive (VNA) & PACS Market by Modality
11.1.6.1 North America Computed Tomography Market by Country
11.1.6.2 North America Mammography Market by Country
11.1.6.3 North America MRI Market by Country
11.1.6.4 North America Ultrasound Market by Country
11.1.6.5 North America X-Rays Market by Country
11.1.6.6 North America PET Market by Country
11.1.7 North America Vendor Neutral Archive (VNA) & PACS Market by Country
11.1.7.1 US Vendor Neutral Archive (VNA) & PACS Market
11.1.7.1.1 US Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.7.1.1.1 US Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.7.1.1.2 US Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.7.1.2 US Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.7.1.3 US Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.7.1.4 US Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.7.1.5 US Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.7.1.6 US Vendor Neutral Archive (VNA) & PACS Market by Modality
11.1.7.2 Canada Vendor Neutral Archive (VNA) & PACS Market
11.1.7.2.1 Canada Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.7.2.1.1 Canada Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.7.2.1.2 Canada Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.7.2.2 Canada Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.7.2.3 Canada Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.7.2.4 Canada Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.7.2.5 Canada Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.7.2.6 Canada Vendor Neutral Archive (VNA) & PACS Market by Modality
11.1.7.3 Mexico Vendor Neutral Archive (VNA) & PACS Market
11.1.7.3.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.7.3.1.1 Mexico Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.7.3.1.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.7.3.2 Mexico Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.7.3.3 Mexico Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.7.3.4 Mexico Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.7.3.5 Mexico Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.7.3.6 Mexico Vendor Neutral Archive (VNA) & PACS Market by Modality
11.1.7.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market
11.1.7.4.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.1.7.4.1.1 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.1.7.4.1.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.1.7.4.2 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.1.7.4.3 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.1.7.4.4 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by End User
11.1.7.4.5 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Application
11.1.7.4.6 Rest of North America Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2 Europe Vendor Neutral Archive (VNA) & PACS Market
11.2.1 Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.1.1 Europe VNA Market by Country
11.2.1.2 Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.1.2.1 Europe Multi-Department VNA Market by Country
11.2.1.2.2 Europe Department VNA Market by Country
11.2.1.2.3 Europe Multi-Site VNA Market by Country
11.2.1.3 Europe PACS Market by Country
11.2.1.4 Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.1.4.1 Europe Multi-Department PACS Market by Country
11.2.1.4.2 Europe Department PACS Market by Country
11.2.1.4.3 Europe Multi-Site PACS Market by Country
11.2.2 Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.2.1 Europe Independent Vendor Market by Country
11.2.2.2 Europe Third-party Vendor Market by Country
11.2.3 Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.3.1 Europe On-Premise Market by Country
11.2.3.2 Europe Cloud-Based Market by Country
11.2.3.3 Europe Hybrid Model Market by Country
11.2.4 Europe Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.4.1 Europe Hospitals & Clinics Market by Country
11.2.4.2 Europe Diagnostic Centers Market by Country
11.2.4.3 Europe Others Market by Country
11.2.5 Europe Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.5.1 Europe Cardiology Market by Country
11.2.5.2 Europe Orthopedic Market by Country
11.2.5.3 Europe Oncology Market by Country
11.2.5.4 Europe Neurology Market by Country
11.2.5.5 Europe Obstetrics & Gynecology Market by Country
11.2.5.6 Europe Others Market by Country
11.2.6 Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.6.1 Europe Computed Tomography Market by Country
11.2.6.2 Europe Mammography Market by Country
11.2.6.3 Europe MRI Market by Country
11.2.6.4 Europe Ultrasound Market by Country
11.2.6.5 Europe X-Rays Market by Country
11.2.6.6 Europe PET Market by Country
11.2.7 Europe Vendor Neutral Archive (VNA) & PACS Market by Country
11.2.7.1 Germany Vendor Neutral Archive (VNA) & PACS Market
11.2.7.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.1.1.1 Germany Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.1.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.1.2 Germany Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.1.3 Germany Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.1.4 Germany Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.1.5 Germany Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.1.6 Germany Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.2 UK Vendor Neutral Archive (VNA) & PACS Market
11.2.7.2.1 UK Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.2.1.1 UK Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.2.1.2 UK Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.2.2 UK Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.2.3 UK Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.2.4 UK Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.2.5 UK Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.2.6 UK Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.3 France Vendor Neutral Archive (VNA) & PACS Market
11.2.7.3.1 France Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.3.1.1 France Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.3.1.2 France Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.3.2 France Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.3.3 France Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.3.4 France Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.3.5 France Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.3.6 France Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.4 Russia Vendor Neutral Archive (VNA) & PACS Market
11.2.7.4.1 Russia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.4.1.1 Russia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.4.1.2 Russia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.4.2 Russia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.4.3 Russia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.4.4 Russia Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.4.5 Russia Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.4.6 Russia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.5 Spain Vendor Neutral Archive (VNA) & PACS Market
11.2.7.5.1 Spain Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.5.1.1 Spain Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.5.1.2 Spain Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.5.2 Spain Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.5.3 Spain Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.5.4 Spain Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.5.5 Spain Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.5.6 Spain Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.6 Italy Vendor Neutral Archive (VNA) & PACS Market
11.2.7.6.1 Italy Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.6.1.1 Italy Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.6.1.2 Italy Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.6.2 Italy Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.6.3 Italy Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.6.4 Italy Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.6.5 Italy Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.6.6 Italy Vendor Neutral Archive (VNA) & PACS Market by Modality
11.2.7.7 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market
11.2.7.7.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.2.7.7.1.1 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.2.7.7.1.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.2.7.7.2 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.2.7.7.3 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.2.7.7.4 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by End User
11.2.7.7.5 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Application
11.2.7.7.6 Rest of Europe Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market
11.3.1 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.1.1 Asia Pacific VNA Market by Country
11.3.1.2 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.1.2.1 Asia Pacific Multi-Department VNA Market by Country
11.3.1.2.2 Asia Pacific Department VNA Market by Country
11.3.1.2.3 Asia Pacific Multi-Site VNA Market by Country
11.3.1.3 Asia Pacific PACS Market by Country
11.3.1.4 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.1.4.1 Asia Pacific Multi-Department PACS Market by Country
11.3.1.4.2 Asia Pacific Department PACS Market by Country
11.3.1.4.3 Asia Pacific Multi-Site PACS Market by Country
11.3.2 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.2.1 Asia Pacific Independent Vendor Market by Country
11.3.2.2 Asia Pacific Third-party Vendor Market by Country
11.3.3 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.3.1 Asia Pacific On-Premise Market by Country
11.3.3.2 Asia Pacific Cloud-Based Market by Country
11.3.3.3 Asia Pacific Hybrid Model Market by Country
11.3.4 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.4.1 Asia Pacific Hospitals & Clinics Market by Country
11.3.4.2 Asia Pacific Diagnostic Centers Market by Country
11.3.4.3 Asia Pacific Others Market by Country
11.3.5 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.5.1 Asia Pacific Cardiology Market by Country
11.3.5.2 Asia Pacific Orthopedic Market by Country
11.3.5.3 Asia Pacific Oncology Market by Country
11.3.5.4 Asia Pacific Neurology Market by Country
11.3.5.5 Asia Pacific Obstetrics & Gynecology Market by Country
11.3.5.6 Asia Pacific Others Market by Country
11.3.6 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.6.1 Asia Pacific Computed Tomography Market by Country
11.3.6.2 Asia Pacific Mammography Market by Country
11.3.6.3 Asia Pacific MRI Market by Country
11.3.6.4 Asia Pacific Ultrasound Market by Country
11.3.6.5 Asia Pacific X-Rays Market by Country
11.3.6.6 Asia Pacific PET Market by Country
11.3.7 Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Country
11.3.7.1 China Vendor Neutral Archive (VNA) & PACS Market
11.3.7.1.1 China Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.1.1.1 China Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.1.1.2 China Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.1.2 China Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.1.3 China Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.1.4 China Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.1.5 China Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.1.6 China Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.2 Japan Vendor Neutral Archive (VNA) & PACS Market
11.3.7.2.1 Japan Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.2.1.1 Japan Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.2.1.2 Japan Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.2.2 Japan Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.2.3 Japan Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.2.4 Japan Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.2.5 Japan Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.2.6 Japan Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.3 India Vendor Neutral Archive (VNA) & PACS Market
11.3.7.3.1 India Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.3.1.1 India Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.3.1.2 India Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.3.2 India Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.3.3 India Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.3.4 India Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.3.5 India Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.3.6 India Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.4 South Korea Vendor Neutral Archive (VNA) & PACS Market
11.3.7.4.1 South Korea Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.4.1.1 South Korea Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.4.1.2 South Korea Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.4.2 South Korea Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.4.3 South Korea Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.4.4 South Korea Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.4.5 South Korea Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.4.6 South Korea Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.5 Singapore Vendor Neutral Archive (VNA) & PACS Market
11.3.7.5.1 Singapore Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.5.1.1 Singapore Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.5.1.2 Singapore Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.5.2 Singapore Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.5.3 Singapore Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.5.4 Singapore Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.5.5 Singapore Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.5.6 Singapore Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.6 Malaysia Vendor Neutral Archive (VNA) & PACS Market
11.3.7.6.1 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.6.1.1 Malaysia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.6.1.2 Malaysia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.6.2 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.6.3 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.6.4 Malaysia Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.6.5 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.6.6 Malaysia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.3.7.7 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market
11.3.7.7.1 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.3.7.7.1.1 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.3.7.7.1.2 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.3.7.7.2 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.3.7.7.3 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.3.7.7.4 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by End User
11.3.7.7.5 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Application
11.3.7.7.6 Rest of Asia Pacific Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market
11.4.1 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.1.1 LAMEA VNA Market by Country
11.4.1.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.1.2.1 LAMEA Multi-Department VNA Market by Country
11.4.1.2.2 LAMEA Department VNA Market by Country
11.4.1.2.3 LAMEA Multi-Site VNA Market by Country
11.4.1.3 LAMEA PACS Market by Country
11.4.1.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.1.4.1 LAMEA Multi-Department PACS Market by Country
11.4.1.4.2 LAMEA Department PACS Market by Country
11.4.1.4.3 LAMEA Multi-Site PACS Market by Country
11.4.2 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.2.1 LAMEA Independent Vendor Market by Country
11.4.2.2 LAMEA Third-party Vendor Market by Country
11.4.3 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.3.1 LAMEA On-Premise Market by Country
11.4.3.2 LAMEA Cloud-Based Market by Country
11.4.3.3 LAMEA Hybrid Model Market by Country
11.4.4 LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.4.1 LAMEA Hospitals & Clinics Market by Country
11.4.4.2 LAMEA Diagnostic Centers Market by Country
11.4.4.3 LAMEA Others Market by Country
11.4.5 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.5.1 LAMEA Cardiology Market by Country
11.4.5.2 LAMEA Orthopedic Market by Country
11.4.5.3 LAMEA Oncology Market by Country
11.4.5.4 LAMEA Neurology Market by Country
11.4.5.5 LAMEA Obstetrics & Gynecology Market by Country
11.4.5.6 LAMEA Others Market by Country
11.4.6 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.6.1 LAMEA Computed Tomography Market by Country
11.4.6.2 LAMEA Mammography Market by Country
11.4.6.3 LAMEA MRI Market by Country
11.4.6.4 LAMEA Ultrasound Market by Country
11.4.6.5 LAMEA X-Rays Market by Country
11.4.6.6 LAMEA PET Market by Country
11.4.7 LAMEA Vendor Neutral Archive (VNA) & PACS Market by Country
11.4.7.1 Brazil Vendor Neutral Archive (VNA) & PACS Market
11.4.7.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.1.1.1 Brazil Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.1.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.1.2 Brazil Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.1.3 Brazil Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.1.4 Brazil Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.1.5 Brazil Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.1.6 Brazil Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.2 Argentina Vendor Neutral Archive (VNA) & PACS Market
11.4.7.2.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.2.1.1 Argentina Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.2.1.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.2.2 Argentina Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.2.3 Argentina Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.2.4 Argentina Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.2.5 Argentina Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.2.6 Argentina Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.3 UAE Vendor Neutral Archive (VNA) & PACS Market
11.4.7.3.1 UAE Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.3.1.1 UAE Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.3.1.2 UAE Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.3.2 UAE Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.3.3 UAE Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.3.4 UAE Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.3.5 UAE Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.3.6 UAE Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market
11.4.7.4.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.4.1.1 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.4.1.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.4.2 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.4.3 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.4.4 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.4.5 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.4.6 Saudi Arabia Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.5 South Africa Vendor Neutral Archive (VNA) & PACS Market
11.4.7.5.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.5.1.1 South Africa Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.5.1.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.5.2 South Africa Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.5.3 South Africa Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.5.4 South Africa Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.5.5 South Africa Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.5.6 South Africa Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market
11.4.7.6.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.6.1.1 Nigeria Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.6.1.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.6.2 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.6.3 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.6.4 Nigeria Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.6.5 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.6.6 Nigeria Vendor Neutral Archive (VNA) & PACS Market by Modality
11.4.7.7 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market
11.4.7.7.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Product Type
11.4.7.7.1.1 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by VNA Type
11.4.7.7.1.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by PACS Type
11.4.7.7.2 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Vendor Type
11.4.7.7.3 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Deployment
11.4.7.7.4 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by End User
11.4.7.7.5 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Application
11.4.7.7.6 Rest of LAMEA Vendor Neutral Archive (VNA) & PACS Market by Modality
Chapter 12. Company Profiles
12.1 Hyland Software, Inc.
12.1.1 Company Overview
12.1.2 Recent strategies and developments
12.1.2.1 Partnerships, Collaborations, and Agreements
12.1.2.2 Product Launches and Product Expansions
12.2 GE HealthCare Technologies, Inc.
12.2.1 Company Overview
12.2.2 Financial Analysis
12.2.3 Segmental and Regional Analysis
12.2.4 Research & Development Expenses
12.2.5 Recent strategies and developments
12.2.5.1 Partnerships, Collaborations, and Agreements
12.2.6 SWOT Analysis
12.3 Koninklijke Philips N.V.
12.3.1 Company Overview
12.3.2 Financial Analysis
12.3.3 Segmental and Regional Analysis
12.3.4 Research & Development Expense
12.3.5 Recent strategies and developments
12.3.5.1 Partnerships, Collaborations, and Agreements
12.3.6 SWOT Analysis
12.4 Siemens Healthineers AG (Siemens AG)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.4.3 Segmental and Regional Analysis
12.4.4 Research & Development Expense
12.4.5 Recent strategies and developments
12.4.5.1 Partnerships, Collaborations, and Agreements
12.4.6 SWOT Analysis
12.5 Fujifilm Holdings Corporation
12.5.1 Company Overview
12.5.2 Financial Analysis
12.5.3 Segmental and Regional Analysis
12.5.4 Research & Development Expenses
12.5.5 Recent strategies and developments
12.5.5.1 Product Launches and Product Expansions
12.5.5.2 Acquisition and Mergers
12.5.6 SWOT Analysis
12.6 IBM Corporation
12.6.1 Company Overview
12.6.2 Financial Analysis
12.6.3 Regional & Segmental Analysis
12.6.4 Research & Development Expenses
12.6.5 Recent strategies and developments
12.6.5.1 Product Launches and Product Expansions
12.6.6 SWOT Analysis
12.7 Carestream Health, Inc. (Onex Corporation)
12.7.1 Company Overview
12.7.2 SWOT Analysis
12.8 Novarad Enterprise Healthcare Solutions
12.8.1 Company Overview
12.8.2 Recent strategies and developments
12.8.2.1 Partnerships, Collaborations, and Agreements
12.8.2.2 Product Launches and Product Expansions
12.8.3 SWOT Analysis
12.9 Canon, Inc. (Canon Medical Systems Corporation)
12.9.1 Company Overview
12.9.2 Financial Analysis
12.9.3 Segmental and Regional Analysis
12.9.4 Research & Development Expenses
12.9.5 Recent strategies and developments
12.9.5.1 Partnerships, Collaborations, and Agreements
12.9.5.2 Product Launches and Product Expansions
12.9.6 SWOT Analysis
12.10. INFINITT Healthcare Co. Ltd.
12.10.1 Company Overview
12.10.2 Recent strategies and developments
12.10.2.1 Partnerships, Collaborations, and Agreements
12.10.2.2 Product Launches and Product Expansions
12.10.3 SWOT Analysis
Chapter 13. Winning Imperatives for Vendor Neutral Archive (VNA) & PACS Market

Companies Mentioned

Some of the key companies in the Vendor Neutral Archive (VNA) & PACS Market include:
  • Hyland Software, Inc.
  • GE HealthCare Technologies, Inc.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG (Siemens AG)
  • Fujifilm Holdings Corporation
  • IBM Corporation
  • Carestream Health, Inc. (Onex Corporation)
  • Novarad Enterprise Healthcare Solutions
  • Canon, Inc. (Canon Medical Systems Corporation)
  • INFINITT Healthcare Co. Ltd.

Methodology

Loading
LOADING...